PERFAN

This brand name is authorized in Malta, Netherlands, UK.

Active ingredients

The drug PERFAN contains one active pharmaceutical ingredient (API):

1	Enoximone UNII C7Z4ITI7L7 - ENOXIMONE
	Enoximone, an imidazolone, has both positive inotropic and vasolidator properties, inhibiting cardiac phosphodiesterase III with an increase in cAMP.
	Read more about Enoximone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PERFAN Concentrate for solution for injection or infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01CE03	Enoximone	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CE Phosphodiesterase inhibitors
Discover more medicines within C01CE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	40836
MT	Medicines Authority	AA565/42501
NL	Z-Index G-Standaard	14628147
NL	Z-Index G-Standaard, PRK	29386